Do the requirements on collateral only apply to the fraction of assets that reduces the counterparty risk of the UCITS to the limit imposed by the UCITS Directive?

For OTC financial derivative transactions that are centrally cleared and subject to the reporting obligation of EMIR, can UCITS management companies rely on the valuation provided by the central counterparty (CCP)?

Does the «announcement» of the interim or year-end financial results determines the timing of the closed period referred to in Article 19(11) of Regulation (EU) No 596/2014 (MAR)?

Are EuSEF and EuVECA funds allowed to use the designations “EuSEF” or “EuVECA”, respectively, even if they are only marketed in their home Member State?

Can a UCITS invest in a UCITS feeder fund?